NeoGenomics, Inc. (NEO)
NASDAQ: NEO · Real-Time Price · USD
10.26
-1.18 (-10.31%)
At close: Feb 18, 2026, 4:00 PM EST
10.21
-0.05 (-0.49%)
After-hours: Feb 18, 2026, 5:51 PM EST

NeoGenomics Revenue

In the year 2025, NeoGenomics had annual revenue of $727.33M with 10.11% growth. NeoGenomics had revenue of $190.17M in the quarter ending December 31, 2025, with 10.56% growth.

Revenue (ttm)
$727.33M
Revenue Growth
+10.11%
P/S Ratio
1.83
Revenue / Employee
$330,605
Employees
2,500
Market Cap
1.33B

Revenue Chart

Revenue History

Fiscal Year EndRevenueChangeGrowth
Dec 31, 2025727.33M66.77M10.11%
Dec 31, 2024660.57M68.92M11.65%
Dec 31, 2023591.64M81.92M16.07%
Dec 31, 2022509.73M25.40M5.24%
Dec 31, 2021484.33M39.88M8.97%
Dec 31, 2020444.45M35.62M8.71%
Dec 31, 2019408.83M132.09M47.73%
Dec 31, 2018276.74M36.49M15.19%
Dec 31, 2017240.25M8.44M3.64%
Dec 31, 2016231.81M132.01M132.27%
Dec 31, 201599.80M12.73M14.62%
Dec 31, 201487.07M20.60M31.00%
Dec 31, 201366.47M6.60M11.02%
Dec 31, 201259.87M16.38M37.68%
Dec 31, 201143.48M9.11M26.51%
Dec 31, 201034.37M4.90M16.63%
Dec 31, 200929.47M9.45M47.23%
Dec 31, 200820.02M8.51M73.97%
Dec 31, 200711.50M5.03M77.65%
Dec 31, 20066.48M--

Revenue Definition

Revenue, also called sales, is the amount of money a company receives from its business activities, such as sales of products or services. Revenue does not take any expenses into account and is therefore different from profits.

Full Definition

Related Stocks

Company NameRevenue
Neogen880.32M
OPKO Health642.07M
Veracyte495.14M
GeneDx Holdings402.19M
Twist Bioscience391.56M
CareDx358.00M
Castle Biosciences343.53M
Fulgent Genetics315.55M
Revenue Rankings